Back

Discussion - GENETIC-AF

27 May 2018 (09:10 - 09:15)
Organised by:
Congress Presentation Part of: Late breaking trial II - Chronic heart failure Chronic Heart Failure HFA Premium Access Heart Failure 2018

11 More presentations in this session

Presentation thumbnail
The HF-Wii study: Improving exercise capacity of patients with heart failure through exergaming: Secondary outcomes and per protocol analysis of an international multicenter RCT
Professor T. Jaarsma (Linkoping, SE)
Slides Video
Presentation thumbnail
Discussion - HF-Wii
Video
Presentation thumbnail
Diabetes and obesity in heart failure: a crossroads for prognosis and the efficacy of beta-blockers
Professor D. Kotecha (Birmingham, GB)
Slides Video
Presentation thumbnail
Discussion - BB-meta-HF
Video
Presentation thumbnail
Phase ii trial of pharmacogenetic guided beta-blocker therapy with bucindolol vs. metoprolol for the prevention of atrial fibrillation/flutter in heart failure: GENETIC-AF
Professor W. Abraham (Columbus, US)
Slides Video

Access the full session

Session thumbnail
Late breaking trial II - Chronic heart failure

The Event

Event poster

Heart Failure 2018

27 May 2018 09:10 CET
You may be interested in
thumbnail
Congress Presentation
Discussion – How genes and the environment interact to shape individual CV risk
14 April 2023
thumbnail
Congress Presentation
Genetic aspects associated with increased risk of developing atrial fibrillation
15 June 2024
thumbnail
Congress Session
Clinical course of specific cardiomyopathies
18 May 2025
thumbnail
Congress Session
Genetics: primary arrhythmia syndromes and sudden cardiac death
1 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources